Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does NT-proBNP testing reduce costs and improve accuracy in the diagnosis of heart failure?

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 652–653 (2007)Cite this article

boxed-textMoe GW et al. (2007) N-terminal pro-B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF study. Circulation 115: 3103–3110

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Maisel AS et al. for the Breathing Not Properly Multinational Study Investigators (2002) Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161–167

    Article  CAS  Google Scholar 

  2. Januzzi JL et al. (2006) NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 27: 330–337

    Article  CAS  Google Scholar 

  3. Hunt SA et al. (2005) ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112: e154—e235

    Article  Google Scholar 

  4. Mueller C et al. (2004) Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350: 647–654

    Article  CAS  Google Scholar 

  5. Breidthardt T et al. (2007) Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea. Clin Chem 53: 1415–1422

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Medicine, Christchurch School of Medicine and Health Sciences, University of Otago, PO Box 4345, Christchurch, New Zealand mark.richards@cdhb.govt.nz

Authors and Affiliations

  1. AM Richards holds the National Heart Foundation of New Zealand Chair of Cardiovascular Studies and directs the Christchurch Cardioendocrine Research Group at the Christchurch School of Medicine and Health Sciences, University of Otago, Christchurch, New Zealand.,

    A Mark Richards

Authors
  1. A Mark Richards
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

AM Richards has acted as a Consultant and received research support from Biosite and Roche Diagnostics. He has also received Speakers' Bureau honoraria from Roche Diagnostics.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Richards, A. Does NT-proBNP testing reduce costs and improve accuracy in the diagnosis of heart failure?. Nat Rev Cardiol 4, 652–653 (2007). https://doi.org/10.1038/ncpcardio1014

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio1014

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing